Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 93,632 | 69,828 | 54,570 |
| Cost of Goods | 0 | 0 | 74,308 | 58,205 | 48,156 |
| Gross Profit | 0 | 0 | 19,324 | 11,623 | 6,414 |
| Operating Expenses | 5,406 | 3,100 | 19,119 | 26,118 | 44,571 |
| Operating Income | -5,406 | -3,100 | 513 | -14,290 | -38,001 |
| Interest Expense | 1,486 | 29 | 15 | 97 | 0 |
| Other Income | -1,063 | 246 | -214 | 484 | -459 |
| Pre-tax Income | -7,955 | -2,883 | 284 | -13,903 | -38,460 |
| Income Tax | N/A | N/A | 374 | 184 | 167 |
| Net Income Continuous | -7,955 | -2,883 | -90 | -14,087 | -38,627 |
| Net Income Discontinuous | -12,702 | -30,765 | N/A | N/A | N/A |
| Net Income | $-20,657 | $-33,648 | $-90 | $-14,087 | $-38,627 |
| EPS Basic Total Ops | -28.58 | -128.37 | -0.36 | -88.13 | -733.81 |
| EPS Basic Continuous Ops | -11.00 | -11.00 | -0.38 | -87.70 | -734.03 |
| EPS Basic Discontinuous Ops | -17.58 | -117.37 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -28.58 | -128.37 | -0.36 | -88.13 | -733.81 |
| EPS Diluted Continuous Ops | -11.00 | -11.00 | -0.38 | -87.70 | -734.03 |
| EPS Diluted Discontinuous Ops | -17.58 | -117.37 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | 0.00 | -88.13 | -733.81 |
| EBITDA(a) | $-1,106 | $457 | $2,719 | $-11,915 | $-35,872 |